Download in electronic PDF format for $25



Search the Complete Journal Archives

Imatinib 40-mg/mL Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue

Abstract:  A formulation for preparing Imatinib 40-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, imatninib, formulation, hazardous medication, antineoplastic agent, cancer, leukemia, gastrointestinal stromal tumor, GIST, protein tyrosine kinase inhibitor, BCR-ABL inhibitor, receptor tyrosine kinase inhibitor, platelet-derived growth factor receptor, PDGF, PDGFR, stem cell factor inhibitor, SCF, c-kit inhibitor

Related Categories: CANCER AND AIDS, FORMULATIONS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Imatinib 40-mg/mL Oral Suspension Allen Loyd V Jr Nov/Dec 2016 510 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso Jul/Aug 2014 278-286 Buy
Sunitinib 10-mg/mL Oral Suspension Allen Loyd V Jr May/Jun 2010 248 Buy
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Corsini Lindsay, Williams LaVonn A Mar/Apr 2011 124-128 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310 Buy
Lapatinib Ditosylate 50-mg/mL Oral Suspension Allen Loyd V Jr Nov/Dec 2016 511 Buy
Erlotinib 10-mg/mL Oral Suspension Allen Loyd V Jr Nov/Dec 2016 508 Buy
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject Biundo Bruce Mar/Apr 2010 100-104 Buy